We do not start with a famous name or a universal ranking. We start with the patient's diagnosis, then look for the doctor, department, safety systems and practical support that fit that case.
No single badge, review score, price or success claim decides the result. We combine clinical relevance, verifiable evidence, operational readiness and patient-specific practical needs.
We begin with the diagnosis, treatment already received, current condition and the type of specialist or multidisciplinary team required. A strong general reputation does not make every hospital suitable for every case.
We look for a relevant qualification, professional registration, current hospital role and experience aligned with the proposed treatment. Titles and affiliations are reconfirmed when a patient is ready to proceed.
We assess the actual department, not only the hospital brand. The required operating theatre, imaging, laboratory, pathology, radiotherapy, rehabilitation or transplant infrastructure must be available for the proposed pathway.
Procedure volume can be useful when it is current, treatment-specific and interpreted with patient complexity. We do not treat an unsupported high number as proof of quality.
For complex surgery, cancer treatment, transplantation and high-risk patients, we consider ICU capability, anaesthesia, emergency response, blood-bank access and specialist backup.
We look for current evidence of patient-identification, medication, surgical-safety, sterilisation, infection-prevention and incident-management processes. A logo alone does not show how a system works in practice.
NABH or JCI accreditation is useful evidence of evaluated systems, but it is not an outcome guarantee. We verify the facility, programme and validity period rather than assuming accreditation applies to an entire hospital group.
The hospital should state the proposed treatment, expected stay, professional fees, major inclusions, exclusions, implant or medicine assumptions, payment terms and circumstances that could change the price.
We consider communication, interpreters, medical-visa documentation, records, discharge planning and a practical follow-up route after the patient returns home.
Official hospital and doctor profiles, professional registers, accreditation directories, regulatory bodies and written provider confirmation.
The relevant department, consultant, technology, critical-care support and expected pathway for the individual case.
Definition, time period, patient group, case complexity, sample size and whether the figure is audited or independently published.
Current availability, appointment format, admission process, estimate, invitation-letter requirements and follow-up contact.
Patient reviews are supporting context, not proof of clinical quality. Reviews can help reveal communication or service patterns, but they cannot establish competence, safety or expected outcomes for another patient.
We review the diagnosis, available records, current condition, previous treatment and the decision the patient needs to make.
We identify the relevant specialty, level of care, technology, multidisciplinary support and likely admission pathway.
Potential doctors and hospitals are screened against the case rather than selected from a generic ranking.
We recheck the proposed consultant, hospital unit, appointment availability and the information most relevant to the case.
With the patient's permission, records are sent to appropriate providers for a clinical response and itemised estimate.
We organise what is known, what remains uncertain and which questions the patient should ask before deciding.
A high procedure count or success percentage can sound decisive, but the number may be misleading unless the hospital explains how it was calculated.
A red flag does not always prove misconduct. It means the claim or process needs clarification before it can support a patient decision.
We confirm the relevant transplant programme, multidisciplinary team, donor pathway, critical care and the applicable authorisation requirements. No shortcut around Indian transplant law is accepted.
Pathology, staging, radiology, surgical oncology, medical oncology and radiation oncology may all affect the plan. Access to one treatment does not replace a complete case review.
The responsible paediatric specialist, anaesthesia, ICU, nursing, safeguarding and family support are checked for the child's age and condition.
We look beyond the operating surgeon to anaesthesia, intensive care, blood bank, imaging, infection response and the ability to manage complications.
NABH and JCI describe systems for healthcare quality and patient safety. WHO surgical-safety guidance reinforces the importance of team communication and consistent checks. We use these frameworks as evidence inputs, not as treatment guarantees.
Quality Council of India benchmarks for healthcare quality and patient safety.
International ↗JCI standardsInternational accreditation and patient-safety standards for healthcare organisations.
Global ↗WHO safe surgeryChecklist and implementation resources designed to reduce errors and improve surgical teamwork.
Verification rule: accreditation is checked against the named facility and current scope. A group-level brand statement or old certificate image is not treated as current facility accreditation.
No. A hospital can be suitable for one condition and unsuitable for another. We compare case-specific clinical capability, the proposed team, safety support, practical fit and written information rather than creating a universal best-hospital ranking.
No. Accreditation is relevant evidence about evaluated quality and safety systems, but it does not guarantee an individual result. The treating department, doctor, procedure experience, critical-care support and current accreditation scope still need to be checked.
TIB HIND coordinates most effectively with hospitals where a working relationship exists, but a commercial relationship does not make a provider clinically suitable. Patients may request another opinion or choose a provider outside the TIB HIND network.
We ask what the outcome means, which patients were included, the time period, sample size, case complexity and whether the figure was audited or published. We do not compare percentages that use different definitions as though they were equivalent.
No. Availability, hospital affiliation and acceptance can change. The hospital and doctor must formally accept the case and confirm the plan. TIB HIND rechecks these details before travel.
No. Payment does not purchase a higher directory position or a case-specific recommendation. Read our financial disclosure for details about how TIB HIND is paid.
Send the medical summary and the question you need answered. We will identify the capabilities that matter before discussing hospitals or costs.